Valeant (VRX) Stock Falls as Ackman Trims Stake to 8.5% – TheStreet.com


Financial Post

Valeant (VRX) Stock Falls as Ackman Trims Stake to 8.5%
TheStreet.com
NEW YORK (TheStreet) -- Valeant Pharmaceuticals (VRX - Get Report) stock is slumping by 3.25% to $98.35 in afternoon trading on Monday after activist investor Bill Ackman's Pershing Square Capital Management lowered its stake in the specialty ...
Valeant CEO Pearson on medical leave, company being run by 3-man exec groupBioPharma Dive
Communications lessons learned from shareholder activismPR Week
Biotech Warriors in Hot Glance: Chimerix, Inc. (NASDAQ:CMRX), Valeant ...StreetWise Report (press release)
PharmaLive (press release) (subscription) -Schaeffers Research (blog) -USA TODAY -ValueWalk
all 131 news articles »